Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Blinklab Limited ( (AU:BB1) ) has issued an announcement.
BlinkLab Limited has announced the introduction of an AI-powered smartphone platform aimed at improving the early and accurate diagnosis of Autism and ADHD. This innovative platform is expected to significantly impact the company’s operations by enhancing its market positioning in the neurological testing industry, potentially offering valuable insights and benefits for stakeholders involved in healthcare and technology sectors.
More about Blinklab Limited
BlinkLab Limited operates in the technology industry, focusing on developing AI-powered platforms for neurological testing. Their primary product is a smartphone application designed to aid in the early and accurate diagnosis of neurological conditions such as Autism and ADHD.
Average Trading Volume: 320,098
Technical Sentiment Signal: Buy
Current Market Cap: A$114.4M
For detailed information about BB1 stock, go to TipRanks’ Stock Analysis page.